DR THIERRY COOMANS DE BRACHENE,ALGEMENE GENEESKUNDE financials
A multi-period view of the public annual-account figures reported for DR THIERRY COOMANS DE BRACHENE,ALGEMENE GENEESKUNDE, with comparable measures and links to available source documents.
Company overviewRegistry number
0808839547
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for DR THIERRY COOMANS DE BRACHENE,ALGEMENE GENEESKUNDE
2025 versus 2024
- Operating line
- €138,412
- EBITDA
- €134,888
- Total assets
- €342,862
- Equity
- €199,179
+1.1%
-0.4%
+12.7%
-24.1%
EBITDA margin +97.5% · Equity ratio +58.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Sept 2025 | €138,412 | €134,888 | €342,862 | €199,179 | - |
| 202430 Sept 2024 | €136,883 | €135,369 | €304,252 | €262,543 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.